"Innovative medicine for everyone, everywhere"
Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity.
The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.
For more information, visit our website: www.adocia.com
For careers offers, please click to the following link : https://www.adocia.com/careers/adocia-careers/
Company Details
- Employees
- 92
- Founded
- -
- Address
- 115 Avenue Lacassagne, Lyon,69003,france
- Phone
- 33472610610
- em****@****cia.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- adocia.com
- Keywords
- Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, Diabetes, Metabolic diseases, Amylin, Innovative protein formulations, Glucagon, Insulin, GLP-1, Obesity, Cell therapy, Transplantation of Islets of Langherans, Long acting injectables, Oral formulation of peptides.
- HQ
- LYON
Adocia Questions
Adocia's helpline number is 33472610610
Adocia's website is adocia.com
Adocia's LinkedIn profile is https://fr.linkedin.com/company/adocia
Adocia has
92 employees.
View email and phone details for 92
employees at Adocia.
Adocia's industry is
Biotechnology Research
Adocia's top competitors are
Bioaster,
Cellectis,
Theranexus,
Enyo Pharma,
Abivax,
Genfit,
Phaxiam Therapeutics,
Maat Pharma,
Innate Pharma,
Transgene.
Adocia's support email address is emploi@adocia.com
Adocia's categories are Biotechnology Research
Adocia's founding year is 2005
